Abstract
Oral delivery of vaccines is able to induce systemic as well as mucosal immune responses but is largely inefficient due to intestinal degradation and impermeable barrier property of GIT of administered antigen. Efforts are being made to develop a safe and effective oral vaccination by offering resistant against acidic and enzymatic degradation before reaching to the target site. Several strategies are developed to target antigen to the gut associated lymphoid tissue (GALT) present in the intestine where antigen-specific immune responses are initiated. This review discusses various technologies and targets for antigen delivery to induce protective immunization by oral vaccine.
Keywords: M-cell ligand, mucosal immunity, nanocarriers, oral vaccine.
Current Drug Therapy
Title:Newer Technologies in Oral Vaccine Delivery
Volume: 9 Issue: 3
Author(s): Jayamanti Pandit, Yasmin Sultana and Mohd. Abul Kalam
Affiliation:
Keywords: M-cell ligand, mucosal immunity, nanocarriers, oral vaccine.
Abstract: Oral delivery of vaccines is able to induce systemic as well as mucosal immune responses but is largely inefficient due to intestinal degradation and impermeable barrier property of GIT of administered antigen. Efforts are being made to develop a safe and effective oral vaccination by offering resistant against acidic and enzymatic degradation before reaching to the target site. Several strategies are developed to target antigen to the gut associated lymphoid tissue (GALT) present in the intestine where antigen-specific immune responses are initiated. This review discusses various technologies and targets for antigen delivery to induce protective immunization by oral vaccine.
Export Options
About this article
Cite this article as:
Pandit Jayamanti, Sultana Yasmin and Kalam Abul Mohd., Newer Technologies in Oral Vaccine Delivery, Current Drug Therapy 2014; 9 (3) . https://dx.doi.org/10.2174/1574885509666141202232803
DOI https://dx.doi.org/10.2174/1574885509666141202232803 |
Print ISSN 1574-8855 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3903 |
Call for Papers in Thematic Issues
Novel Therapeutic Approaches and Biomarkers for Chronic Kidney Disease (CKD)
The thematic issue on "Novel Therapeutic Approaches and Biomarkers for CKD" aims to provide a comprehensive exploration of cutting-edge strategies for the management of chronic kidney disease (CKD). This issue will delve into emerging therapeutic targets, focusing on critical aspects such as podocyte injury, endothelial dysfunction, and tubulointerstitial fibrosis, which ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Mesenchymal Stem/Stromal Cells: A New "Cells as Drugs" Paradigm. Efficacy and Critical Aspects in Cell Therapy
Current Pharmaceutical Design Metabotropic Glutamate Receptors in Central Nervous System Diseases
Current Drug Targets Cysteinet Dysregulation in Muscular Dystrophies: A Pathogenic Network Susceptible to Therapy
Current Medicinal Chemistry Subject Index to Volume 3
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Pathological Roles of Iron in Cardiovascular Disease
Current Drug Targets Anti-Inflammatory Intervention for Acute Liver Failure: Recent Patents and Future Targets
Recent Patents on Biomarkers Not Only a Clinical Nightmare: Amniotic Fluid Embolism in Court
Current Pharmaceutical Biotechnology Trafficking of Natural Killer Cells
Current Molecular Medicine Role of Chemokines and Trafficking of Immune Cells in Parasitic Infections
Current Immunology Reviews (Discontinued) Some Recent Approaches of Biologically Active Substituted Pyridazine and Phthalazine Drugs
Current Medicinal Chemistry Deciphering the Systems Biology of mTOR Inhibition by Integrative Transcriptome Analysis
Current Pharmaceutical Design Electronegative LDL: An Active Player in Atherogenesis or a By- Product of Atherosclerosis?
Current Medicinal Chemistry Pharmacological Potential of Tetrahydrofurano/Pyrano Quinoline and Benzo[b]furoindolyl Derivatives in Acute Inflammation, Pain and Oxidative Stress
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry BRCA1 as Target for Breast Cancer Prevention and Therapy
Anti-Cancer Agents in Medicinal Chemistry Hair Growth: Focus on Herbal Therapeutic Agent
Current Drug Discovery Technologies Hypoxia Inducible Factor-1α, Endothelial Progenitor Cells, Monocytes,Cardiovascular Risk, Wound Healing, Cobalt and Hydralazine:A Unifying Hypothesis
Current Drug Targets Targeting Schistosome Histone Modifying Enzymes for Drug Development
Current Pharmaceutical Design Hepatic Stellate Cell: A Potential Target for Hepatocellular Carcinoma
Current Molecular Pharmacology Cancer Immunotherapy Using Gene-Modified Dendritic Cells
Current Gene Therapy Phosphatidylinositol 3-Kinase Isoforms as Novel Drug Targets
Current Drug Targets